PIRS
$3.48
Pieris Pharma
($.10)
(2.79%)
PIRS
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.20)
Revenue:  $7.78 Mil
Monday
Aug 16
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when PIRS reports earnings?
Beat
Meet
Miss

Where is PIRS's stock price going from here?
Up
Flat
Down
Stock chart of PIRS
Analysts
Summary of analysts' recommendations for PIRS
Score
Grade
Pivots
Resistance
$4.05
$3.92
$3.70

$3.58

Support
$3.36
$3.23
$3.01
Tweet
Growth
Description
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.